Objective
The overall objective of the Infravec2 project is to integrate key specialized research facilities necessary for European excellence in insect vector biology, to open the infrastructure for European access, and to develop new vector control measures targeting the greatest threats to human health and animal industries. Infravec2 is an Advanced Community, following a four-year Starting Community lifecycle (FP7 Infravec1). Lack of access to key infrastructures limits European vector research and impedes development of vector control measures. Insect vectors transmit parasitic diseases such as malaria and leishmaniasis, and viral infections such as chikungunya, dengue, Zika, Japanese encephalitis and yellow fever. Vector-borne diseases, which have historically been a problem of tropical countries, now represent a threat for temperate regions of the world including much of Europe. The 24 consortium partners, including 4 commercial companies, hold the major European biosecure insectaries for experimental infection and containment of insect vectors under Containment Level 2 and 3 (CL2/CL3) conditions, other key insect vector facilities, and include front-line field sites in Africa, the Pacific, and the Americas. Infravec2 will implement comparable standards across the secure insectary facilities as a world first, improving exploitation of European vector infrastructures for research and public health, and will develop other innovative methodologies and technologies. Networking activities will assure that the project achieves full impact, producing a step change in European vector biology research and the product pipeline, and consolidating European global leadership in insect vectors. The goal of the Infravec2 project is to build a durable European infrastructure to control insect vector-borne disease, including with power to predict and prevent the inevitable next epidemic outbreak in advance.
Fields of science
- medical and health scienceshealth sciencesinfectious diseasesmalaria
- medical and health scienceshealth sciencespublic healthepidemiologyepidemics prevention
- medical and health sciencesmedical biotechnologygenetic engineering
- natural sciencesbiological scienceszoologyentomology
- natural sciencesbiological scienceszoologyinvertebrate zoology
Programme(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
75724 Paris Cedex 15
France
See on map
Participants (24)
G12 8QQ Glasgow
See on map
53100 Siena
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
13572 Marseille
See on map
98845 Noumea
See on map
116 36 Praha 1
See on map
75016 Paris
See on map
SW7 2AZ London
See on map
08140 Caldes De Montbui Barcelona
See on map
69117 Heidelberg
See on map
GU24 0NF Woking
See on map
40014 Crevalcore
See on map
6534AT Nijmegen
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
80539 Munchen
See on map
70013 Irakleio
See on map
Participation ended
6525 XZ Nijmegen
21000 Novi Sad
See on map
8006 Zurich
See on map
L35QA Liverpool
See on map
DAKAR Dakar
See on map
BP1805 Bamako
See on map
1002 Lausanne
See on map
6708 PB Wageningen
See on map
7003 Ouagadougou
See on map
6525 GA Nijmegen
See on map